TECH EBITDA | BIO-TECHNE Corp

BIO-TECHNE Corp (TECH) EBITDA

2026-06-30: Basis Reported; EBITDA $98.42M; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $99.66M*; Operating income $75.50M; Depreciation and amortization $24.17M*.
2025-12-31: Basis Reported; EBITDA $79.17M*; Operating income $54.46M; Depreciation and amortization $24.71M*.
2025-09-30: Basis Reported; EBITDA $72M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-06-30 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$98.42M	(m)	(m)	(m)	30.64%	(m)	(m)	(m)	(m)	(m)	(m)
2026-03-31	Reported	$99.66M*	$75.50M	$24.17M*	$311.42M	32.00%*	$9.09M*	$86.66M*	$103.13M	(m)	$109.34M	$20.18M
2025-12-31	Reported	$79.17M*	$54.46M	$24.71M*	$295.88M	26.76%*	$5.92M*	$82.41M*	$104.60M	(m)	$113.69M	$12.78M
2025-09-30	Reported	$72M	(m)	(m)	(m)	25.13%	$5.36M	$27.59M	$98.44M	(m)	$116.21M	$9.81M
2025-06-30	Reported	$3.25M	(m)	(m)	(m)	1.03%	(m)	(m)	(m)	(m)	(m)	(m)
2025-03-31	Reported	$66.28M*	$38.71M	$27.57M*	$316.18M	20.96%*	$10.12M*	$41.12M*	$101.63M	(m)	$151.27M	$15.69M
2024-12-31	Reported	$74.50M*	$47.42M	$27.08M*	$297.03M	25.08%*	$6.82M*	$84.35M*	$103.14M	(m)	$121.45M	$7.99M
2024-09-30	Reported	$68.12M	(m)	(m)	(m)	23.54%	$9.17M	$63.89M	$106.44M	(m)	$119.16M	$6.57M
2024-06-30	Reported	$73.88M	(m)	(m)	(m)	24.14%	(m)	(m)	(m)	(m)	(m)	(m)
2024-03-31	Reported	$94.31M*	$67.00M	$27.31M*	$303.43M	31.08%*	$16.44M*	$80.99M*	$98.83M	(m)	$111.84M	$12.03M
2023-12-31	Reported	$65.81M*	$38.00M	$27.80M*	$272.60M	24.14%*	$14.86M*	$83.12M*	$96.01M	(m)	$115.67M	$5.92M
2023-09-30	Reported	$84.4M	(m)	(m)	(m)	30.48%	$13.59M	$59.38M	$91.74M	(m)	$105.33M	-$1.44M
2023-06-30	Reported	$121.45M	(m)	(m)	(m)	40.31%	(m)	(m)	(m)	(m)	(m)	(m)
2023-03-31	Reported	$107.18M*	$80.21M	$26.97M*	$294.15M	36.44%*	$11.75M*	$50.53M*	$91.98M	(m)	$99.24M	$9.98M
2022-12-31	Reported	$94.59M*	$67.89M	$26.70M*	$271.58M	34.83%*	$6.11M*	$64.38M*	$88.22M	(m)	$93.01M	$16.42M
2022-09-30	Reported	$82.96M	(m)	(m)	(m)	30.76%	$9.56M	$56.08M	$90.06M	(m)	$99.38M	$13.98M
2022-06-30	Reported	$106.44M	(m)	(m)	(m)	36.93%	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	Reported	$115.81M*	$90.45M	$25.37M*	$290.38M	39.88%*	$15.10M*	$73.13M*	$88.92M	(m)	$89.27M	$8.63M
2021-12-31	Reported	$87.45M*	$62.35M	$25.10M*	$269.28M	32.48%*	$10.17M*	$100.99M*	$85.58M	(m)	$100.69M	$14.12M
2021-09-30	Reported	$87.96M	(m)	(m)	(m)	34.13%	$6.07M	$48.43M	$86.72M	(m)	$86.17M	-$1.60M
2021-06-30	Reported	$93.25M	(m)	(m)	(m)	36.00%	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Reported	$89.73M*	$68.63M	$21.10M*	$243.55M	36.84%*	$10.60M*	$74.87M*	$75.28M	(m)	$82.60M	-$48.00K
2020-12-31	Reported	$71.88M*	$50.99M	$20.88M*	$224.25M	32.05%*	$11.45M*	$89.27M*	$73.35M	(m)	$83.12M	$10.22M
2020-09-30	Reported	$70.18M	(m)	(m)	(m)	34.37%	$10.94M	$66.01M	$66.47M	(m)	$72.60M	$5.94M
2020-06-30	Reported	$60.3M	(m)	(m)	(m)	34.29%	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Reported	$68.90M*	$47.79M	$21.11M*	$194.68M	35.39%*	$9.28M*	$49.47M*	$64.62M	(m)	$66.32M	$10.39M
2019-12-31	Reported	$57.55M*	$36.99M	$20.55M*	$184.93M	31.12%*	$14.56M*	$70.42M*	$63.53M	(m)	$68.03M	$30.70M
2019-09-30	Reported	$53.41M	(m)	(m)	(m)	29.15%	$10.53M	$40.54M	$64.83M	(m)	$69.01M	$3.41M
2019-06-30	Reported	$63.18M	(m)	(m)	(m)	32.97%	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Reported	$63.41M*	$44.09M	$19.32M*	$184.86M	34.30%*	$4.92M*	$39.66M*	$60.25M	(m)	$64.97M	$5.22M
2018-12-31	Reported	$53.48M*	$33.60M	$19.88M*	$174.51M	30.65%*	$4.60M*	$46.56M*	$61.49M	(m)	$63.60M	$4.21M
2018-09-30	Reported	$44.82M	(m)	(m)	(m)	27.50%	$4.19M	$39.45M	$55.37M	(m)	$67.05M	$183.00K
2018-06-30	Reported	$60.07M	(m)	(m)	(m)	33.32%	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Reported	$59.36M*	$43.08M	$16.27M*	$163.97M	36.20%*	$3.51M*	$21.65M*	$53.71M	(m)	$53.28M	$5.24M
2017-12-31	Reported	$39.76M*	$24.15M	$15.62M*	$154.15M	25.79%*	$6.33M*	$39.18M*	$52.32M	(m)	$63.77M	-$27.12M
2017-09-30	Reported	$41.45M	(m)	(m)	(m)	28.67%	$5.27M	$44.70M	$46.74M	(m)	$58.29M	$7.10M
2017-06-30	Reported	$54.79M	(m)	(m)	(m)	34.99%	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Reported	$49.54M*	$33.50M	$16.04M*	(m)	(m)	$4.02M*	$25.02M*	$47.35M	(m)	$49.41M	$8.97M
2016-12-31	Reported	$33.49M*	$17.88M	$15.61M*	(m)	(m)	$2.85M*	(m)	$43.66M	(m)	$56.98M	$7.72M
2016-09-30	Reported	$42.8M	(m)	(m)	(m)	32.78%	$2.44M	(m)	$43.24M	(m)	$45.42M	$8.94M
2016-06-30	Reported	$50.67M	(m)	(m)	(m)	37.60%	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Reported	$54.35M*	$43.53M	$10.83M*	(m)	(m)	$2.84M*	(m)	$40.98M	(m)	$35.22M	$12.20M
2015-12-31	Reported	$46.62M*	$36.02M	$10.59M*	(m)	(m)	$4.89M*	(m)	$39.32M	(m)	$34.59M	$9.52M
2015-09-30	Reported	$41.71M	(m)	(m)	(m)	37.12%	$6.12M	(m)	$36.99M	(m)	$33.04M	$9.14M
2015-06-30	Reported	$47.3M	(m)	(m)	(m)	40.20%	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Reported	$48.70M*	$39.43M	$9.27M*	(m)	(m)	$4.92M*	(m)	$34.78M	(m)	$29.09M	$14.47M
2014-12-31	Reported	$44.48M*	$34.58M	$9.89M*	(m)	(m)	$3.14M*	(m)	$36.20M	(m)	$31.14M	$9.35M
2014-09-30	Reported	$43.78M	(m)	(m)	(m)	40.35%	$4.91M	(m)	$35.41M	(m)	$28.70M	$10.69M
2014-06-30	Reported	$44.16M	(m)	(m)	(m)	47.73%	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Reported	$50.69M*	$45.77M	$4.92M*	(m)	(m)	$4.26M*	$34.93M*	$27.44M	(m)	$14.67M	$14.43M
2013-12-31	Reported	$40.60M*	$35.74M	$4.86M*	(m)	(m)	$3.65M*	$31.32M*	$25.42M	(m)	$14.93M	$11.16M
2013-09-30	Reported	$43.48M	(m)	(m)	(m)	50.76%	$3.81M	$32.59M	$24.55M	(m)	$14.02M	$12.23M
2013-06-30	Reported	-$115.45M	(m)	(m)	(m)	-145.27%	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Reported	$46.95M*	$43.95M	$3.00M*	(m)	(m)	$6.37M*	$33.02M*	$19.84M	(m)	$9.98M	$11.35M
2012-12-31	Reported	$40.08M*	$36.90M	$3.17M*	(m)	(m)	$8.22M*	$31.29M*	$19.82M	(m)	$10.96M	$12.08M
2012-09-30	Reported	$40.91M	(m)	(m)	(m)	54.53%	$2.52M	$29.26M	$19.44M	(m)	$10.33M	$12.32M
2012-06-30	Reported	$44.32M	(m)	(m)	(m)	56.33%	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Reported	$49.41M*	$46.36M	$3.05M*	(m)	(m)	$1.59M*	$34.46M*	$20.24M	(m)	$9.90M	$11.45M
2011-12-31	Reported	$40.86M*	$37.68M	$3.18M*	(m)	(m)	$2.20M*	$20.44M*	$19.49M	(m)	$10.65M	$12.06M
2011-09-30	Reported	$44.08M	(m)	(m)	(m)	56.81%	$1.10M	$34.43M	$19.21M	(m)	$10.77M	$12.98M
2011-06-30	Reported	$45.36M	(m)	(m)	(m)	58.13%	(m)	(m)	(m)	(m)	(m)	(m)
2011-03-31	Reported	$46.62M*	$44.74M	$1.88M*	(m)	(m)	$592.00K*	$32.39M*	$15.94M	(m)	$9.29M	$14.32M
2010-12-31	Reported	$39.40M*	$37.35M	$2.05M*	(m)	(m)	$713.00K*	$29.43M*	$15.33M	(m)	$8.43M	$11.14M
2010-09-30	Reported	$40.37M	(m)	(m)	(m)	59.42%	$1.05M	$30.70M	$15.35M	(m)	$7.61M	$12.58M
2010-06-30	Reported	$40.99M	(m)	(m)	(m)	61.44%	(m)	(m)	(m)	(m)	(m)	(m)
2010-03-31	Reported	$43.65M*	$41.65M	$2.00M*	(m)	(m)	$1.37M*	$23.22M*	$14.40M	(m)	$7.67M	$9.05M
2009-12-31	Reported	$38.61M*	$36.55M	$2.06M*	(m)	(m)	$1.59M*	$28.23M*	$13.33M	(m)	$9.01M	$11.98M
2009-09-30	Reported	$41.21M	(m)	(m)	(m)	61.93%	$563.00K	$28.03M	$12.90M	(m)	$8.04M	$12.94M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$349.25M	(m)	(m)	(m)	28.74%	$28.85M	$292.07M	$415.97M	(m)	$452.42M	$58.82M
2025-06-30	Reported	$212.16M	(m)	(m)	(m)	17.40%	$31.01M	$287.56M	$429.36M	(m)	$588.52M	$25.06M
2024-06-30	Reported	$318.4M	(m)	(m)	(m)	27.47%	$62.88M	$298.98M	$389.33M	(m)	$466.38M	$17.58M
2023-06-30	Reported	$406.18M	(m)	(m)	(m)	35.73%	$38.24M	$254.39M	$366.89M	(m)	$378.38M	$53.22M
2022-06-30	Reported	$397.66M	(m)	(m)	(m)	35.97%	$44.91M	$325.27M	$349.10M	(m)	$372.77M	$38.29M
2021-06-30	Reported	$325.04M	(m)	(m)	(m)	34.91%	$44.30M	$352.16M	$298.18M	(m)	$324.95M	$8.59M
2020-06-30	Reported	$240.16M	(m)	(m)	(m)	32.51%	$51.74M	$205.22M	$255.50M	(m)	$260.58M	$47.18M
2019-06-30	Reported	$224.89M	(m)	(m)	(m)	31.50%	$25.41M	$181.62M	$240.51M	(m)	$264.36M	$15.94M
2018-06-30	Reported	$200.64M	(m)	(m)	(m)	31.20%	$20.93M	$170.37M	$210.85M	(m)	$240.64M	-$198.00K
2017-06-30	Reported	$180.62M	(m)	(m)	(m)	32.08%	$15.18M	$143.72M	$188.46M	(m)	$200.44M	$35.88M
2016-06-30	Reported	$193.36M	(m)	(m)	(m)	38.75%	$16.90M	$144.16M	$162.36M	(m)	$140.88M	$43.01M
2015-06-30	Reported	$184.25M	(m)	(m)	(m)	40.74%	$19.91M	(m)	$144.97M	(m)	$119.40M	$46.43M
2014-06-30	Reported	$178.93M	(m)	(m)	(m)	50.01%	$13.82M	(m)	$106.35M	(m)	$60.72M	$50.44M
2013-06-30	Reported	$12.48M	(m)	(m)	(m)	4.02%	$22.45M	$123.56M	$79.47M	(m)	$43.38M	$48.10M
2012-06-30	Reported	$178.68M	(m)	(m)	(m)	56.80%	$6.02M	$126.75M	$78.76M	(m)	$41.68M	$49.86M
2011-06-30	Reported	$171.76M	(m)	(m)	(m)	59.23%	$3.63M	$127.19M	$65.03M	(m)	$35.90M	$52.68M
2010-06-30	Reported	$164.46M	(m)	(m)	(m)	61.13%	$4.64M	$111.26M	$54.90M	(m)	$32.70M	$46.67M
2009-06-30	Reported	$158.55M	(m)	(m)	(m)	60.07%	$6.56M	$111.32M	$55.92M	(m)	$33.69M	$50.12M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78